Interrelationships Between Infliximab and Recombinant Tumor Necrosis Factor- Α in Plasma Using Minimal Physiologically Based Pharmacokinetic Models
Drug Metabolism and Disposition - United States
doi 10.1124/dmd.116.074807
Full Text
Open PDFAbstract
Available in full text
Date
April 14, 2017
Authors
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)